Investigation of the genomic representation of plasma DNA in pregnant women by comparative genomic hybridization analysis: A feasibility study

Clinical Chemistry

Volumn 51, Issue 12, 2005, Pages 2398-2401

  Chan, K C Allen ^a   Hui, Angela B Y ^a   Wong, Nathalie ^a   Lau, Tze K ^a   Leung, Tse N ^a   Lo, Kwok Wai ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DNA; DNA FRAGMENT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; BETA THALASSEMIA; BLOOD GROUP RHESUS SYSTEM; BLOOD SAMPLING; CHORION VILLUS SAMPLING; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DNA DETERMINATION; FEASIBILITY STUDY; FEMALE; GENE DOSAGE; GESTATIONAL AGE; HONG KONG; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MATERNAL PLASMA; MYOTONIC DYSTROPHY; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; QUANTITATIVE ANALYSIS;

DNA; FEASIBILITY STUDIES; FEMALE; GENOME, HUMAN; GENOMICS; HEALTH; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 28044468166     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.055434     Document Type: Article

References (21)

1. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of materna plasma. N Engl J Med 1998;339:1734-8.
2. Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der School CE. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998;352:1196.
3. Chen CP, Chern SR, Wang W. Fetal DNA in maternal plasma: the prenatal detection of a paternally inherited fetal aneuploidy. Prenat Diagn 2000;20:355-7.
4. Chen CP, Chern SR, Wang W. Fetal DNA analyzed in plasma from a mother's three consecutive pregnancies to detect paternally inherited aneuploidy. Clin Chem 2001;47:937-9.
5. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301-2.
6. Chiu RWK, Lau TK, Gong ZQ, Cheung PT, Leung TN, Lo YMD. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002;48:778-80.
7. Chiu RWK, Lau TK, Leung TN, Chow KC, Chui DH, Lo YMD. Prenatal exclusion of β thalassaemia major by examination of maternal plasma. Lancet 2002;360:998-1000.
8. Ding C, Chiu RWK, Lau TK, Leung TN, Chan LC, Chan AY, et al. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004;101:10762-7.
9. Chan KCA, Zhang J, Hui ABY, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92.
10. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for β-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293:843-9.
11. Lo YMD, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
12. Sekizawa A, Farina A, Koide K, Iwasaki M, Honma S, Ichizuka K, et al. β-Globin DNA in maternal plasma as a molecular marker of pre-eclampsia. Prenat Diagn 2004;24:697-700.
13. Zhong XY, Burk MR, Troeger C, Kang A, Holzgreve W, Hahn S. Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol 2000;96:991-6.
14. Chiu RWK, Poon LLM, Lau TK, Leung TN, Wong EMC, Lo YMD. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-13.
15. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, et al. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 1992;4:257-63.
16. Lo YMD, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-8.
17. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184:414-9.
18. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okal T. Total cell-free DNA (β-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn 2004;24:722-6.
19. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2:1035-7.
20. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
21. Lo YMD, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319-23.